| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A randomised phase III trial
|
Nabid, Abdenour
|
|
|
143 |
C |
p. 64-74
|
artikel
|
| 2 |
Bilateral radiation recall pneumonitis during immunotherapy for an advanced renal cell carcinoma: A challenging case enhances the need for a multidisciplinary approach
|
De Giglio, Andrea
|
|
|
143 |
C |
p. 75-77
|
artikel
|
| 3 |
Cancers emerging early in adulthood: Analysis of trends and patterns in European cancer registries
|
Scelo, Ghislaine
|
|
|
143 |
C |
p. 33-39
|
artikel
|
| 4 |
Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
|
Prager, Gerald W.
|
|
|
143 |
C |
p. 101-112
|
artikel
|
| 5 |
Completion of radical hysterectomy does not improve survival of patients with cervical cancer and intraoperatively detected lymph node involvement: ABRAX international retrospective cohort study
|
Cibula, D.
|
|
|
143 |
C |
p. 88-100
|
artikel
|
| 6 |
Consideration regarding immune checkpoint inhibitor–induced secondary adrenal insufficiency in patients lacking human leucocyte antigen-DR15
|
Kanzaki, Akinori
|
|
|
143 |
C |
p. 52-54
|
artikel
|
| 7 |
CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment
|
Kurtz, Jean-Emmanuel
|
|
|
143 |
C |
p. 78-87
|
artikel
|
| 8 |
Dabrafenib–trametinib combination therapy re-challenge in advanced BRAF V600E-mutant non–small-cell lung cancer
|
Kashizaki, Fumihiro
|
|
|
143 |
C |
p. 31-32
|
artikel
|
| 9 |
Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study
|
Appelbaum, Limor
|
|
|
143 |
C |
p. 19-30
|
artikel
|
| 10 |
Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer
|
Kim, Chang Gon
|
|
|
143 |
C |
p. 113-126
|
artikel
|
| 11 |
Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer
|
Koivuluoma, Susanna
|
|
|
143 |
C |
p. 46-51
|
artikel
|
| 12 |
Financial toxicity and cancer treatments: Help from biosimilars – The explanatory case of bevacizumab
|
Giuliani, Jacopo
|
|
|
143 |
C |
p. 40-42
|
artikel
|
| 13 |
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy
|
Pfob, André
|
|
|
143 |
C |
p. 134-146
|
artikel
|
| 14 |
Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by Pfob et al.
|
Dubsky, Peter
|
|
|
143 |
C |
p. 178-179
|
artikel
|
| 15 |
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study
|
Molina, Thierry J.
|
|
|
143 |
C |
p. 158-167
|
artikel
|
| 16 |
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study
|
Culié, Dorian
|
|
|
143 |
C |
p. 168-177
|
artikel
|
| 17 |
Prognostic significance of an 11-gene RNA assay in archival tissue of cutaneous melanoma stage I–III patients
|
Gambichler, Thilo
|
|
|
143 |
C |
p. 11-18
|
artikel
|
| 18 |
Surveillance of patients with conjunctival melanoma in German-speaking countries: A multinational survey of the German dermatologic cooperative oncology group
|
Wessely, Anja
|
|
|
143 |
C |
p. 43-45
|
artikel
|
| 19 |
The prognostic significance of anaplasia in childhood rhabdomyosarcoma: A report from the Children's Oncology Group
|
Shenoy, Archana
|
|
|
143 |
C |
p. 127-133
|
artikel
|
| 20 |
The spleen as an organ at risk in paediatric radiotherapy: A SIOP-Europe Radiation Oncology Working Group report
|
Arunagiri, Niruthiga
|
|
|
143 |
C |
p. 1-10
|
artikel
|
| 21 |
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial
|
Boilève, Alice
|
|
|
143 |
C |
p. 55-63
|
artikel
|
| 22 |
Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools
|
Gerratana, Lorenzo
|
|
|
143 |
C |
p. 147-157
|
artikel
|
Tijdschrift beschrijving